News Conference News SCAI 2024 Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows L.A. McKeown May 06, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News EuroPCR 2022 Registry Data Hint at MACE Benefit With Renal Denervation Michael O'Riordan May 17, 2022
News Conference News TCT 2021 Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints Todd Neale November 04, 2021
News Conference News TCT 2021 NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy L.A. McKeown October 22, 2021
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020
News Conference News CRT 2020 AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3 L.A. McKeown February 27, 2020
News Conference News HRS 2019 ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost? Todd Neale May 10, 2019
News Conference News ACC 2019 Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO Michael O'Riordan April 01, 2019
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
News Conference News AHA 2013 Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients Jason Kahn November 17, 2013
News Conference News AHA 2013 Long-term Outcomes with Renal Denervation Show Sustained Benefit Yael L. Maxwell November 16, 2013
News Conference News Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy Jason Kahn May 18, 2011